BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12893366)

  • 1. Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma.
    Bamias A; Chorti M; Deliveliotis C; Trakas N; Skolarikos A; Protogerou B; Legaki S; Tsakalou G; Tamvakis N; Dimopoulos MA
    Urology; 2003 Aug; 62(2):368-73. PubMed ID: 12893366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma.
    Zhang Y; Sun B; Zhao X; Liu Z; Wang X; Yao X; Dong X; Chi J
    J Surg Oncol; 2013 Nov; 108(6):414-9. PubMed ID: 23996537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma.
    Rioux-Leclercq N; Epstein JI; Bansard JY; Turlin B; Patard JJ; Manunta A; Chan T; Ramee MP; Lobel B; Moulinoux JP
    Hum Pathol; 2001 Nov; 32(11):1209-15. PubMed ID: 11727260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in renal cell carcinoma.
    Tawfik OW; Kramer B; Shideler B; Danley M; Kimler BF; Holzbeierlein J
    Arch Pathol Lab Med; 2007 Feb; 131(2):261-7. PubMed ID: 17284111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD44 and P53 in renal cell carcinoma: association with tumor subtypes.
    Noroozinia F; Fahmideh AN; Yekta Z; Rouhrazi H; Rasmi Y
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):79-84. PubMed ID: 24434386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence.
    Gilcrease MZ; Guzman-Paz M; Niehans G; Cherwitz D; McCarthy JB; Albores-Saavedra J
    Cancer; 1999 Dec; 86(11):2320-6. PubMed ID: 10590373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
    Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
    Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
    Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
    Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of epithelial membrane antigen and vimentin in the diagnosis of chromophobe renal cell carcinoma.
    Khoury JD; Abrahams NA; Levin HS; MacLennan GT
    Ann Diagn Pathol; 2002 Jun; 6(3):154-8. PubMed ID: 12089725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-β (PDGF-β), and PDGF-β receptor expression in papillary renal cell carcinoma.
    Kim M; Sohn M; Shim M; Choi SK; Park M; Kim E; Go H; Park Y; Cho YM; Ro JY; Jeong IG; Song C; Hong JH; Kim CS; Ahn H
    Hum Pathol; 2017 Mar; 61():78-89. PubMed ID: 27989785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma.
    Grankvist K; Ljungberg B; Rasmuson T
    Int J Cancer; 1997 Apr; 74(2):233-6. PubMed ID: 9133462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of tissue-based biomarker signature in clear cell renal cell carcinoma.
    Haddad AQ; Luo JH; Krabbe LM; Darwish O; Gayed B; Youssef R; Kapur P; Rakheja D; Lotan Y; Sagalowsky A; Margulis V
    BJU Int; 2017 May; 119(5):741-747. PubMed ID: 28075543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
    Khurana KK; Truong LD; Verani RR
    Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
    Tsui KH; Shvarts O; Smith RB; Figlin RA; deKernion JB; Belldegrun A
    J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of conventional and new prognostic factors for locally confined renal cell carcinoma.
    Hofmockel G; Tsatalpas P; Müller H; Dämmrich J; Poot M; Maurer-Schultze B; Müller-Hermelink HK; Frohmüller HG; Bassukas ID
    Cancer; 1995 Jul; 76(2):296-306. PubMed ID: 8625106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of immunocytochemistry in distinguishing between clear cell carcinoma of the kidney and ovary.
    Nolan LP; Heatley MK
    Int J Gynecol Pathol; 2001 Apr; 20(2):155-9. PubMed ID: 11293161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic value of CD44 isoforms in transitional cell carcinoma of renal pelvis and ureter.
    Masuda M; Takano Y; Iki M; Makiyama K; Noguchi S; Hosaka M
    J Urol; 1999 Mar; 161(3):805-8; discussion 808-9. PubMed ID: 10022688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: a multicenter study.
    Hefler LA; Rosen AC; Graf AH; Lahousen M; Klein M; Leodolter S; Reinthaller A; Kainz C; Tempfer CB
    Cancer; 2000 Oct; 89(7):1555-60. PubMed ID: 11013371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.